The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders. Since that time, nearly 4,000 members have joined the society from around the globe.
SOHO is an international society designed specifically for clinicians, research scientists and related health care professionals who specialize in the research and treatment of patients with hematologic malignancies. SOHO’s mission is to expedite worldwide research and education through the exchange of scientific information. Organized by its founders and world class committees, SOHO is the only international society specific to this field.
SOHO is led by a Board of Directors with eight voting members. In addition, an outstanding group of clinician-scientists have been assembled to serve on the Steering Committee to provide guidance and direction in the continued development of SOHO.
Two additional committees, Scientific and Education, are responsible for abstract review and the scientific program of the annual meetings, respectively. A third committee, Publication, is responsible for identifying opportunities for publishing work derived from the Society's activities. In addition, members of the Publication Committee manage the publication of papers for the society's featured article series, "SOHO State of the Art and Next Questions." Members of these groups are listed on the 'Committees' webpage.
The SOHO annual meeting has no parallel general sessions so that delegates may attend all sessions in sequential order. In addition, presentations are limited to the ‘latest advances’ allowing all topics to be covered in only 3.5 days. This year, more than 2,500 hematologic oncology experts gathered from around the world to share the latest clinical research impacting patient treatment at the virtual 8th Annual Meeting of the Society of Hematologic Oncology on September 9-12, 2020. Advances in leukemia, lymphoma, myeloma, myeloproliferative neoplasms, myelodysplastic syndromes and related malignancies were reviewed during the official educational program. All content will remain available through January 12, 2021. For more information and registration, go to soho2020.com.
“Clinical Lymphoma, Myeloma & Leukemia,” a peer-reviewed journal published by Elsevier, is the official journal of SOHO. It is available online free-of-charge to SOHO members and at a discounted rate in printed form (see journal).